Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Mar 24, 2022

SELL
$75.08 - $121.99 $493,651 - $802,084
-6,575 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$112.16 - $174.14 $737,452 - $1.14 Million
6,575 New
6,575 $1.14 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.13B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Sheets Smith Investment Management Portfolio

Follow Sheets Smith Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Investment Management with notifications on news.